
Disc Medicine is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients with hematologic disorders through the development and commercialization of novel therapies.
Disc Medicine revenue
Disc Medicine has not published its revenue, and GetLatka has no sourced estimate yet. Know the figure? Send us a source.
Disc Medicine market cap
Disc Medicine is a public company. Its market capitalisation was $2.5B in September 2026.
Disc Medicine CEO
John Quisel is CEO of Disc Medicine.
- John QuiselCEO
Disc Medicine FAQ
Is Disc Medicine publicly traded?
Yes. Disc Medicine is a public company, with a market capitalisation of $2.5B in September 2026.
Who is the CEO of Disc Medicine?
John Quisel is the CEO of Disc Medicine.
Categories
How this page is sourced
Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.
Updated Sep 28, 2026Data disclaimerReport a correctionClaim this profileRun Disc Medicine? Join the podcast